Why are anticholinergic medications linked to dementia, and does occasional Benadryl use carry the same concern as long-term use?
Acute cognitive effects and an observational long-term association are different questions.
Anticholinergic medicines block acetylcholine signaling. Some can cause short-term drowsiness, confusion or memory difficulty, especially in older adults. Diphenhydramine, the ingredient in many U.S. Benadryl products, has this activity, as do certain bladder medicines and antidepressants. In a prospective cohort of older adults, greater cumulative exposure to strong anticholinergics was associated with higher dementia incidence. The study considered use over years, not simply whether someone had ever taken an antihistamine.[1][2]
That evidence does not mean an occasional dose carries the same risk as regular long-term use, nor can it calculate the dementia risk from a single tablet. Observational studies cannot fully separate drug effects from the conditions being treated or other differences between users. The sensible implication is to review repeated use and the total anticholinergic burden, especially when several medications overlap. A clinician or pharmacist can help assess alternatives when treatment is ongoing. An isolated past dose is not a reason to assume permanent damage.[1][2]
Sources & further reading
- Cumulative strong anticholinergic use and incident dementia
- NIA: research on anticholinergic medicines and cognition
Updated September 24, 2026 · Evidence summaries for understanding research.